These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1269894)

  • 1. [Clinical and morphological studies in patients with a progesterone-releasing intrauterine contraceptive device (Progestasert-System) (author's transl)].
    Sievers S; Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):334-40. PubMed ID: 1269894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The histological reaction of the endometrium to gestagens applied locally].
    Dallenbach-Hellweg G; Sievers S
    Virchows Arch A Pathol Anat Histol; 1975 Nov; 368(4):289-98. PubMed ID: 813368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological study of the endometrium of 459 intrauterine contraceptive device (IUD) users.
    Katsura S; Satodade R
    Yokohama Med Bull; 1969 Oct; 20(5):137-44. PubMed ID: 5402647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices containing progesterone.
    Murad F
    Drug Ther (NY); 1977 May; 7(5):119-21. PubMed ID: 12277687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological reaction of the endometrium to intrauterine administered gestagens].
    Dallenbach-Hellweg G
    Verh Dtsch Ges Pathol; 1975; 59():566. PubMed ID: 1217133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The endometrial bacterial flora following insertion of an intrauterine contraceptive device].
    Wajntraub G; Godfried L; Czaczkes E; Aloni T
    Rev Fr Gynecol Obstet; 1973 Apr; 68(4):241-5. PubMed ID: 17474191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Menstrual and child-bearing functions of women using mechanical and hormonal contraceptives].
    Shinkareva LF; Nagovitsina AI; Zhdanova VI
    Vopr Okhr Materin Det; 1976 Oct; 21(10):72-5. PubMed ID: 997312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium].
    Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI
    J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with the copper-T-intrauterine device (author's transl)].
    Zielske F; Felshart R; Hammerstein J
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):525-39. PubMed ID: 4603400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
    Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
    Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic atypias in the uterine fluid of intrauterine contraceptive device users.
    Kobayashi TK; Casslén B; Stormby N
    Acta Cytol; 1983; 27(2):138-41. PubMed ID: 6573085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraceptive devices: intravaginal and intrauterine delivery systems.
    Benagiano G; Gabelnick H; Farris M
    Expert Rev Med Devices; 2008 Sep; 5(5):639-54. PubMed ID: 18803474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.